Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 58781 - 58800 out of 561203 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices | Injection 162 mg in 0.9 mL single use pre-filled pen, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | Injection 162 mg in 0.9 mL single use pre-filled syringe, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | Injection 162 mg in 0.9 mL single use pre-filled syringe, 4 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | Injection 162 mg in 0.9 mL single use pre-filled syringe, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L04AC07) tocilizumab (adm: P) | Avtozma 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | Injection 162 mg in 0.9 mL single use pre-filled syringe, 4 pcs | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;COVID-19 virus infection | CelltrionHealthcareAustraliaPtyLtd |
Pages
